SynthesisFrontiers in immunology2026
Prognostic utility of circulating tumor DNA assessment in immune checkpoint inhibitor-treated advanced non-small cell lung cancer: a systematic review and meta-analysis.
Yulin Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.